https://www.selleckchem.com/pr....oducts/JNJ-7706621.h
The majority of the clinics (15/19, 79%) offered GLAD® Back to their patients within the study period. Of the participating clinicians, GLAD® Back was delivered by (25/35, 71%) of clinicians. In total, 78 patients were enrolled in the program and (69/78, 88%) participants attended the final assessment. Secondarily, clinicians demonstrated a biomedical and behavioural orientation along with high confidence when treating LBP patients while patient outcomes trended toward improvement. The English translation of the Danish GLAD Back pro